Applied Clinical Trials: March 2009
Groundbreaking ELS Survey on Informed Consent in India Featured in Applied Clinical Trials Magazine
The results of a groundbreaking survey looking at the experience of patients who have completed the informed consent process in India was covered in a special feature within US-based "Applied Clinical Trials" Magazine. The article titled India's Informed Consent, features some results of the survey which included more than 500 respondents at the time of printing. When compared to results from a similar US survey conducted by CenterWatch in 2006, it was revealing to see that despite the newness of the industry in India, Indian patients were remarkably well informed with 86% of patients understanding that they could quit the study at any time, vs 96% in the USA. In addition, 93% of patients in India understood that the study would carry risks and discomforts compared to only 81% in the US.
Click here to read the article.
To view a research brief summarizing the findings of this survey, please click here.
ClinPage.com: June 12, 2009
Story on the Growth in Size and Quality of the Investigative Site Network in India Features ELS Executive Insights on the Business Aspect of Site – Sponsor Relationships
ELS VP of Business Strategy, Dan McDonald was recently interviewed by US-based e-publisher ClinPage.com regarding the dynamics of the investigative site market in India vs. the investigative site markets in more mature markets. The article, titled India: Investigator Snapshot, includes interviews with industry executives and other stakeholders, including insights from McDonald regarding the size and capacity of the site market.
Please click here to register and view the article.
FDA News Device Daily Bulletin: June 15, 2009 | Vol. 6 No. 115
ELS Executives Presentation and Views Featured in FDANews Article.
ELS Executive Director of Operations and Country Head, Dr. Saurendra Das and Vice President of Business Strategy, Dan McDonald was recently interviewed by US-based FDA News publication "FDANews Device Daily Bulletin" e-newsletter. The article, titled Sponsor In-Person Site Visits Essential for Trials in India, includes insights from a presentation given on the importance of ground-based site feasibility analysis in India, by Dr. Das and Mr. McDonald at the 2009 ACRP Annual Meeting in Denver Colorado.
Please click here to register and view the article.
Clinical Trials Advisor: June 25, 2009 | Vol. 14 No. 13
ELS Executives Asked to Weigh in on Clinical Trials Registration
ELS Executive Director of Operations and Country Head Dr. Saurendra Das was recently interviewed by US-based FDA News publication "Clinical Trials Advisor" newsletter. The article, titled Sponsors Must Register Clinical Trials in India, looks at the recent legislation enacted requiring sponsor companies to register clinical trials in a central database when investigative sites from the study are located in India. Please click here to visit the FDA News website to register and read the article.
Please click here to register and view the article
ClinicalTrialsToday.com a CenterWatch weblog: Monday, June 29, 2009 07:00 AM
CenterWatch weblog ClinicalTrialsToday.com features Exciting New Partnership between US-based Excel Life Sciences and Swiss-based PFC Pharma Focus
ClinicalTrialsToday.com has featured ELS in a recent article reporting on an exclusive new partnership between ELS and Swiss-based CRO PFC Pharma Focus. The article, titled Excel Life Sciences and PFC Pharma Focus Open CRO in India describes the partnership between the companies and features several quotes from Dr. Vijai Kumar, President and CMO of ELS, Mohit Mehtrotra, Founder and COO of ELS and Dr. Kurt Pfister, CEO of PFC. For more information, please click on the link below.
Please click here to read the article
|
